News
For the week ending November 18, 2022, a record 5,186 total prescriptions were filled for Adzenys XR-ODT. Adzenys XR-ODT prescriptions are up 9.9% over the preceding thirteen-week period.
Adzenys XR-ODT is bioequivalent to Adderall XR and is the only FDA-approved, extended-release, orally-disintegrating tablet formulation of amphetamine. Adzenys XR-ODT is indicated for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback